Key Moments
- GMR Solutions is seeking a valuation of up to $5 billion through a U.S. IPO on the New York Stock Exchange under the symbol “GMRS”.
- The company plans to raise up to $797.9 million by offering 31.9 million shares in a price range of $22 to $25 per share.
- Funds tied to KKR, Ares and HPS are expected to purchase $350 million of private placement warrants alongside the IPO.
IPO Terms and Valuation
GMR Solutions, the emergency medical services company that operates as Global Medical Response, said on Monday it is aiming for a valuation of up to $5 billion in its U.S. initial public offering as new issuance activity continues into May.
The Lewisville, Texas-based operator intends to raise as much as $797.9 million by selling 31.9 million shares. The proposed price range has been set between $22 and $25 per share.
| IPO Detail | Value |
|---|---|
| Target valuation | $5 billion (up to) |
| Shares offered | 31.9 million |
| Price range per share | $22 – $25 |
| Maximum proceeds targeted | $797.9 million |
| Planned exchange | New York Stock Exchange |
| Ticker symbol | “GMRS” |
Broader IPO Market Backdrop
According to the company, its plans come as the U.S. IPO market has picked up after a short pause in March. The rebound in April was described as one of the strongest months for new offerings in recent years, with several large issuers pricing deals of more than $1 billion. The article cites Renaissance Capital, which focuses on IPO research and ETFs, as the source for that characterization.
AI-chip company Cerebras started its roadshow for a New York listing on the same Monday, an event that is being viewed as a potential tailwind for the broader IPO pipeline.
“If it (Cerebras) performs well, it’ll even help the listing environment for non-AI companies,” said Matt Kennedy, senior strategist at Renaissance Capital.
“Every strong performer and each week of market stability brings us closer to the IPO wave we’ve been anticipating.”
KKR’s Role and GMR’s Evolution
GMR Solutions has a long-standing private equity backer in KKR. The investment firm acquired air ambulance provider Air Medical in 2015 from Bain Capital in a transaction valued at roughly $2 billion.
In 2018, KKR merged Air Medical with American Medical Response, which it had bought from Envision Healthcare for $2.4 billion, to create Global Medical Response. The combined platform has since expanded into a major provider of critical emergency medical services, with operations across about 1,400 U.S. counties.
The company completed a $5.4 billion refinancing in 2025, highlighting the scale of its capital structure.
Capital Structure and Investor Support
As part of the transaction structure surrounding the IPO, funds associated with KKR, Ares and HPS are anticipated to acquire $350 million of private placement warrants.
| Capital and Ownership Highlights | Figure |
|---|---|
| 2015 Air Medical acquisition by KKR | ~$2 billion |
| 2018 American Medical Response acquisition | $2.4 billion |
| GMR refinancing completed | $5.4 billion in 2025 |
| Expected private placement warrants purchase | $350 million |
Underwriting Syndicate
J.P. Morgan, KKR and BofA Securities are listed among the underwriters on the GMR Solutions IPO. Following the offering, the company plans to list its shares on the New York Stock Exchange using the ticker “GMRS”.
TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover 
